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INTRODUCTION:  Even  now,  cystic  duct  cancer  (CDC)  as  deﬁned  by  Farrar  is  rare  and  has  a better  prognosis
than  gallbladder  cancer,  although  CDC  as  deﬁned  by Ozden  et  al., the  deﬁnition  of which  could  apply  to
early and  advanced  cases  of  CDC,  is  not  rare and  has a poorer  prognosis  than  the CDC  deﬁned  by Farrar.
PRESENTATION  OF  CASE:  A 78-year-old  woman  with  no  complaints  was  found  to  have  a tumor  restricted
to  the  cystic  duct. Three  cytology  examinations  of the  patient’s  bile  could  not  establish  that  the  tumor
was  an  adenocarcinoma.  However,  adenocarcinoma  was  suspected  due  to the  hypervascularity  shown  on
contrast-enhanced  computed  tomography.  Cholecystectomy  and  extrahepatic  bile  duct resection  with
D2 lymph  node  dissection  was  performed.  The  pathological  study  revealed  it to be CDC.  Her postoperative
course  has  been  uneventful  and  without  recurrence  for 21 months.
DISCUSSION:  At their ﬁrst  medical  examination,  many  CDC  patients  are  found  to  have  such advanced
spread  of  the  cancer  to adjacent  organs  that  an extended  operation  might  be necessary.  As  in our  case,
better  patient  outcome  results  when  no  lymph  node  or remote  metastasis  is present.
CONCLUSION:  Diagnosing  CDC  as early  as  possible  contributes  to  curative  resections  and favorable  patient
outcomes  and  also  allows  surgeons  to recommend  a mini-invasive  procedure  to their  patients  rather  than
extended  resection  including  that  of  adjacent  organs.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Classic carcinoma originating from the cystic duct, i.e., cystic
uct cancer (CDC) was deﬁned by Farrar as (a) growth restricted to
he cystic duct; (b) absence of neoplasia in the gallbladder, hepatic
ucts, or common bile duct; and (c) histological conﬁrmation of
arcinoma cells in the mass.1 Classic CDC is a rare tumor that has
een identiﬁed in only 2.6% of all bile duct and 1.5% of all gallblad-
er cancers.2–5 Recently, some authors reported that the compared
ith the new classiﬁcation of CDC, CDC deﬁned by the classic deﬁ-
ition of 60 years ago is outdated, and many CDCs are detected only
hen they are at a far advanced stage.6–8 However, patients with
he classically deﬁned CDC have good outcomes after surgery and
ower rates of regional lymph node metastasis than do gallbladder
ancer patients.9 Therefore, diagnosis of and therapy based on the
tatus of classic CDC are very important.
We  report a case of asymptomatic CDC that was  suspected
reoperatively, and we discuss the available diagnostic and
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therapeutic strategies for surgical treatment from our experience
with the present case and with reference to previously reported
cases.
2. Presentation of case
A 78-year-old Japanese woman underwent a medical exam-
ination for symptom-free mild liver dysfunction. The patient
had hypertension and a past history of cerebral infarction.
Enhanced computed tomography (CT) and ultrasonography both
showed a hypervascular tumor of 10 mm in diameter in the cys-
tic duct (Figs. 1 and 2); therefore, additional detailed studies
were undertaken. Laboratory blood tests were normal except for
slight hyperglycemia and a high value of carbohydrate antigen
19-9 (CA19-9) of 99.3 U/ml (normal range: <37 U/ml). A cyto-
logical examination was performed with endoscopic retrograde
cholangiopancreatography (ERCP) rather than magnetic resonance
cholangiopancreatography (MRCP) because CT showed the tumor
to be in the cystic duct. The ERCP revealed an obstruction of the
cystic duct and no pancreaticobiliary maljunction (Fig. 3). Three
cytological examinations of bile taken from the endoscopic naso-
biliary drainage tube did not reveal any cancer cells. However, the
tumor was  suspected to be malignant due to the hypervascularity
shown by CT. No regional lymph node swelling, metastasis or direct
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. Enhanced computed tomography showed a hypervascular tumor, 10 mm in
diameter, in the cystic duct.
Fig. 2. Ultrasonography also showed a tumor of 10 mm in diameter in the cystic
duct.
Fig. 3. Endoscopic retrograde cholangiopancreatography showed an obstruction of
the cystic duct.Fig. 4. The surgically resected specimen comprised a 6.0 mm × 5.0-mm nodular
inﬁltrating tumor (arrow) surrounded by a shallow ulcer, 11 mm × 10 mm in diam-
eter, restricted to the cystic duct.
invasion to adjacent organs was detected on chest and abdominal
CT scans. We  then performed cholecystectomy, extrahepatic bile
duct resection and regional lymph node dissection (D2) followed
by hepaticojejunostomy.
The surgically resected specimen showed a 6.0 mm × 5.0-
mm nodular inﬁltrating tumor surrounded by shallow ulcer,
11 mm  × 10 mm  in diameter, that was  restricted to the cystic duct
(Fig. 4). The pathological study demonstrated the presence of
moderately differentiated tubular adenocarcinoma and classiﬁed
according to the Classiﬁcation of Biliary Tract Carcinoma of the
Japanese Society of Biliary Surgery (2nd English edition) (pStage: II;
invasion level: subserosa; lymphatic duct invasion: not detected;
vessel invasion: not detected; pHinf0, pBinf0, pPV0, pA0, pBM0,
pHM0, pEM0) (Fig. 5). Regional lymph node, liver and distant
metastasis and peritoneal dissemination were not noted (pN0, H0,
M0,  P0). The patient is currently in good health without recurrence
at 21 months after surgery.
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tig. 5. The pathological study revealed the presence of a moderately differentiated
ubular adenocarcinoma (arrows). The dotted arrow indicates the gallbladder wall,
hich contained no malignant cells. (H and E staining, 40×).
. Discussion
Classic primary CDC was deﬁned in 1951 by Farrar,1 but that def-
nition excluded advanced CDC, which invades the gallbladder or
ommon bile duct.6–8 Accordingly, Sasaki et al.,5 Yokoyama et al.6
nd Nakata et al.7 provided new classiﬁcations and clinical and
athological features of CDC, and the CDC based on this new clas-
iﬁcation is not rare, comprising 22–24% of all gallbladder cancers.
owever, even now the CDC fulﬁlling Farrar’s criteria is known
o be rare and to have a better prognosis compared with that in
ocations in the other biliary ducts and the gallbladder.5,9,10 One
eason for this favorable outcome is that the rate of lymph node
etastasis with subserosal-invading CDC (6.7%) is less than that
ith gallbladder cancer (39–46%) and upper and middle-lower bil-
ary duct cancer (38–39%).9,11–13 To date, however, there remains
o good reason why CDC not invading the subserosa results in
ess lymph node metastasis. We  would hypothesize one possible
eason for the problem as follows: the major feeding artery and
rainage vein for the gallbladder are the cystic artery and vein,
espectively, and those for the common bile duct are the hepatic
rtery and portal vein, respectively. Namely, the gallbladder and
he common bile duct are supplied by major “dependable” vessels
ith abundant blood ﬂow. In contrast, the cystic duct has no major
eeding or drainage vessels, excluding blood capillaries from the
our above-mentioned vessels, suggesting that the cystic duct is
ot well supplied by any major “dependable” vessels. This condi-
ion of the cystic duct might be similar to that of lymphatic ﬂow:
undependable” lymphatic ﬂow might play some role in producing
n outcome from CDC that is better than that of the gallbladder can-
ers. At the very least, future oncological, pathological and surgical
tudies will be required to determine the exact cause of the lower
ymph node metastasis seen in many patients with CDC.
Typical symptoms and ﬁndings of CDCs have been reported
y several authors and include right upper quadrant pain, jaun-
ice, fever, hydrops of the gallbladder, and/or increasing serum
otal bilirubin levels, which are usual symptoms of gallbladder
tones due to cystic duct obstruction.7,8,10,14,15 However, there are
ome asymptomatic cases such as that reported by Miura et al.16
nd our case. To detect CDC at an early stage, with the excep-
ion of a gallbladder stone in the cystic duct, the physician must
uspect a mass in the cystic duct if the duct and/or gallbladder
s not imaged by MRCP, ERCP or drip infusion cholecystocholan-
iography CT. After obtaining such diagnostic information and
he patients’ informed consent, the patients can be referred forPEN  ACCESS
rgery Case Reports 5 (2014) 354–357
surgical exploration or resection, as in our case. However, patients
who reject the surgical procedures might need further examina-
tions (e.g., intraductal ultrasonography, contrast-enhanced color
Doppler endoscopic ultrasonography, peroral cholangioscopy or
cytological examination) to determine whether they should be left
treated and closely observed instead. Some authors report that the
typical surgical procedure for CDC is resection of the gallbladder
and the extrahepatic bile duct with lymph node dissection in the
hepatoduodenal ligament14,17 and that for more advanced CDCs,
combined resection with hepatectomy or pancreatoduodenectomy
might be necessary because perineural or lymphatic inﬁltration
can potentially be present in the adjacent organs through hepa-
toduodenal or hepatic routes.6,7,14 However, from the viewpoint of
mini-invasive procedures, open or laparoscopic cholecystectomy
alone might be a mini-invasive approach for early CDC limited to
the cystic duct located close to the gallbladder, as in early gallblad-
der cancer (e.g., depth of mural invasion, m;  mp).18 The procedure
would not be applicable to advanced CDC located close to the
gallbladder because of remnant cancer at the cut end and insuf-
ﬁcient lymph node dissection in the hepatoduodenal ligament.
In contrast, resection of the gallbladder and the extrahepatic bile
duct with lymph node dissection in the hepatoduodenal ligament
are preferable for CDC located close to the common bile duct.18
Moreover, hepatectomy and/or pancreaticoduodenectomy may  be
recommended in patients judged to be tolerant to these proce-
dures and may  offer the possibility of curative resection with a strict
diagnosis of advanced CDC located close to the common bile duct
because of perineural or lymphatic inﬁltration.6,7,14,18
4. Conclusion
In the future, expanded oncological, pathological and surgical
knowledge of CDC might bring many patients a relevant diagno-
sis and allow treatment with a mini-invasive surgical procedure.
Diagnosing CDC as early as possible contributes to the avoidance
of extended resection including that of adjacent organs such as the
pancreas, duodenum or liver. Although there is still room for con-
sideration, cholecystectomy might be preferable as the treatment
for early CDC in some cases.
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1. Cystic duct cancer (CDC) as deﬁned by Farrar is rare and has
 better prognosis than gallbladder cancer.
2. There remains no good reason why CDC not invading the
ubserosa results in less lymph node metastasis.
3. We discuss the available diagnostic and therapeutic strategies
or surgical treatment from our experience with the present case
nd with reference to previously reported cases.
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